IDH2 R172
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| IDH2-Post-Allo-Trial for Patients with IDH2-mut Myeloid Neoplasms After Allo-SCT (NCT04522895) | Heinrich-Heine University, Duesseldorf | 2020-08-27 |
Track IDH2 R172 automatically
Every clearance here is in the API, with alerts when new ones post.